Luciana A. Costa
Universidade Federal do Rio Grande do Sul
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Luciana A. Costa.
Diabetic Medicine | 2004
Luciana A. Costa; Luis Henrique Santos Canani; Hugo Roberto Kurtz Lisboa; Glaucia Sarturi Tres; Jorge Luiz Gross
Aims To investigate the association of features of the metabolic syndrome with the prevalence of chronic complications.
Revista Da Associacao Medica Brasileira | 2004
Rafael Selbach Scheffel; Desirê Bortolanza; Cristiane Seganfredo Weber; Luciana A. Costa; Luis Henrique Santos Canani; Kátia Gonçalves dos Santos; Daisy Crispim; Israel Roisenberg; Hugo Roberto Kurtz Lisboa; Glaucia Sarturi Tres; Balduíno Tschiedel; Jorge Luiz Gross
BACKGROUND: Type 2 diabetes (DM2) has been related to the development of macroangiopatic [coronary heart disease (CHD), peripheral vascular disease (PVD) and stroke] and microangiopatic [retinopathy, nephropathy, and distal sensory neuropathy (DSN)] complications. The aims of this study were to analyze prevalence of complications in DM2 patients and to estimate their associated risk factors. METHODS: Cross-sectional study, including 927 out patients with DM2 from three medical centers in Rio Grande do Sul: Hospital de Clinicas de Porto Alegre (n = 475), Grupo Hospitalar Conceicao (n = 229) and Hospital Sao Vicente de Paula (n = 223). Of the patients 42% were male, mean age was 59 ± 10 years and the median known duration of DM2 was 11 (5 - 43) years. Retinopathy was identified by direct fundoscopy; CHD by WHO questionnaire and/or abnormal ECG and/or perfusion abnormalities on myocardial scintigraphy; DSN by compatible symptoms and absent sensation on 10 g monofilament and/or tune fork; PVD by the presence of claudication and absent foot pulses; stroke by presence of sequels and history; and nephropathy by the urinary albumin excretion rate (>20 µg/min). Hypertension was defined by blood pressure (>140/90 mmHg) and/or use of antihypertensive drugs. Body mass index (BMI, kg/m2) and waist-to-hip ratio (WHR) were calculated. RESULTS: CHD was present in 36% and PVD in 33% of the patients. Among the microvascular, 37% had nephropathy (12% with macroalbuminuria); 48% retinopathy (15% proliferative retinopathy). DSN was present in 36%. Seventy three percent of the patients presented arterial hypertension. Cholesterol levels were >200 mg/dl in 64% and BMI > 30 kg/m2 in 36%. Twenty two percent of patients were smokers and 21% ex-smokers. CONCLUSION: Diabetic complications are frequent among out patients referring to general hospitals. Almost all patients presented at least one risk factor for cardiovascular disease, justifying the efforts for identification and adequate control.
Brazilian Journal of Medical and Biological Research | 2006
M.C. Boelter; Jorge Luiz Gross; Luis Henrique Santos Canani; Luciana A. Costa; H.R. Lisboa; Glaucia Sarturi Tres; Jacó Lavinsky; Mirela Jobim de Azevedo
Diabetic retinopathy is one of the leading causes of blindness in working-age individuals. Diabetic patients with proteinuria or those on dialysis usually present severe forms of diabetic retinopathy, but the association of diabetic retinopathy with early stages of diabetic nephropathy has not been entirely established. A cross-sectional study was conducted on 1214 type 2 diabetic patients to determine whether microalbuminuria is associated with proliferative diabetic retinopathy in these patients. Patients were evaluated by direct and indirect ophthalmoscopy and grouped according to the presence or absence of proliferative diabetic retinopathy. The agreement of diabetic retinopathy classification performed by ophthalmoscopy and by stereoscopic color fundus photographs was 95.1% (kappa = 0.735; P < 0.001). Demographic information, smoking history, anthropometric and blood pressure measurements, glycemic and lipid profile, and urinary albumin were evaluated. On multiple regression analysis, diabetic nephropathy (OR = 5.18, 95% CI = 2.91-9.22, P < 0.001), insulin use (OR = 2.52, 95% CI = 1.47-4.31, P = 0.001) and diabetes duration (OR = 1.04, 95% CI = 1.01-1.07, P = 0.011) were positively associated with proliferative diabetic retinopathy, and body mass index (OR = 0.90, 95% CI = 0.86-0.96, P < 0.001) was negatively associated with it. When patients with macroalbuminuria and on dialysis were excluded, microalbuminuria (OR = 3.3, 95% CI = 1.56-6.98, P = 0.002) remained associated with proliferative diabetic retinopathy. Therefore, type 2 diabetic patients with proliferative diabetic retinopathy more often presented renal involvement, including urinary albumin excretion within the microalbuminuria range. Therefore, all patients with proliferative diabetic retinopathy should undergo an evaluation of renal function including urinary albumin measurements.
Diabetic Medicine | 2005
Luis Henrique Santos Canani; Luciana A. Costa; Daisy Crispim; K. Gonçalves dos Santos; Israel Roisenberg; Hugo Roberto Kurtz Lisboa; G. Sarturi Tres; Ana Luiza Maia; Jorge Luiz Gross
Aim To investigate the association between angiotensin‐converting enzyme gene I/D polymorphism and diabetic nephropathy (DN) in patients with Type 2 diabetes mellitus (DM) taking into consideration the known duration of DM.
Diabetes | 2003
Maria Luiza Caramori; Luis Henrique Santos Canani; Luciana A. Costa; Jorge Luiz Gross
Diabetes Care | 2002
Luciana A. Costa; Luis Henrique Santos Canani; Ana Luiza Maia; Jorge Luiz Gross
Diabetes Research and Clinical Practice | 2006
Luciana A. Costa; Jorge de Faria Maraschin; José X. Castro; Jorge Luiz Gross; Rogério Friedman
Archive | 2003
Jorge Luiz Gross; Sandra Pinho Silveiro; Mirela Jobim de Azevedo; Themis Zelmanovitz; Maria Cristina Boelter; Luciana A. Costa
Archive | 2003
Rafael Selbach Scheffel; Ana Luiza Krahe; Fernanda Stringari; Luciana A. Costa; Miriam Pecis; Lérida Zlavasky
Archive | 2002
Desirê Bortolanza; Rafael Selbach Scheffel; Cristiane Seganfredo Weber; Luciana A. Costa; Luis Henrique Santos Canani; Jorge Luiz Gross